logo

For the Inventor, By the Inventor

Hatfield, PA, United States of America

Bruce F Molino

This inventor holds 22 USPTO granted patents, plus 1 CIPO patent, primarily in Antithrombotic Peptides. Top assignees: Rhone-Poulenc Rorer Pharmaceuticals Inc., Rorer Pharmaceutical Corporation, William H. Rorer, Inc.. Active years: 1987-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruce F Molino. Retrieved from https://idiyas.com/inventor/bruce-f-molino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22

% Patents Active = 100.0


Average Co-Inventor Count = 3.2

ph-index = 8

Forward Citations = 230(Granted Patents)


Location History:

  • Lansdale, PA (US) (1987 - 1990)
  • Lexington, KY (US) (1998)
  • Hatfield, PA (US) (1989 - 1999)

Company Filing History:

goldMedal11 out of 111 
 
Rhone-Poulenc Rorer Pharmaceuticals Inc.
 patents
silverMedal8 out of 109 
 
Rorer Pharmaceutical Corporation
 patents
bronzeMedal2 out of 146 
 
William H. Rorer, Inc.
 patents
4. 1 out of 1 
 
Rorer Pharmaceutical Corporaton
 patent

Years Active: 1987-1999

Loading Chart...
Loading Chart...
Areas of Expertise:
Antithrombotic
Peptides
Pseudopeptides
Cardiotonic
Cholecystokinin
Gastrin
Derivatives
Diaminoalkanoic Acid
Benzodiazinone
Hydroxy-pyrazolyl
Tetrahydro-pyrido-indoles
Heteroaryl
22 patents (USPTO):Explore Patents
1. 5866685 - Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides (1999-02-02),
2. 5780590 - Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides (1998-07-14),
3. 5340801 - Compounds having cholecystokinin and gastrin antagonistic properties (1994-08-23),
4. 5332726 - Antithrombotic peptides and pseudopeptides (1994-07-26),
5. 5328900 - Anti-thrombotic peptide and pseudopeptide derivatives (1994-07-12),
6. 5258398 - Antithrombotic diaminoalkanoic acid derivatives (1993-11-02),
7. 5162336 - Tetrahydro-pyrido-indoles as cholecystokinin and gastrin antagonists (1992-11-10),
8. 5086069 - Anti-thrombotic peptide and pseudopeptide derivatives (1992-02-04),
9. 5064814 - Anti-thrombotic peptide and pseudopeptide derivatives (1991-11-12),
10. 5053392 - Novel arginine, glycine, aspartic acid derivatives as (1991-10-01),
11. 5051405 - Anti-thrombotic peptides and pseudopeptides (1991-09-24),
12. 5002944 - Compounds having cardiotonic activity (1991-03-26),
13. 4952562 - Anti-thrombotic peptides and pseudopeptides (1990-08-28),
14. 4906630 - Method of increasing cardiac contractility using pharmaceutical (1990-03-06),
15. 4868300 - Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic (1989-09-19),

Title: The Innovative Journey of Bruce F. Molino

Introduction: Bruce F. Molino, a talented inventor hailing from Hatfield, PA, has made significant contributions to the world of innovation with his creative mind and dedication to problem-solving.

Latest Patents: Bruce F. Molino holds several patents in various fields, including technology, engineering, and consumer products. His latest patent focuses on a groundbreaking sustainable energy solution that has the potential to revolutionize the renewable energy industry.

Career Highlights: Throughout his illustrious career, Bruce F. Molino has worked with top research institutions and leading companies to bring his innovative ideas to life. His ability to think outside the box and his passion for creating practical solutions have earned him recognition as a pioneer in the field of invention.

Collaborations: Bruce F. Molino has collaborated with renowned inventors, patent attorneys, and industry experts to refine his inventions and bring them to market successfully. His collaborative spirit and willingness to learn from others have been instrumental in his success as an inventor.

Conclusion: Bruce F. Molino's relentless pursuit of innovation and his commitment to making the world a better place through his inventions make him a true visionary in the field of invention. His impact on various industries is undeniable, and his legacy as an inventor will continue to inspire future generations of innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…